SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

A project grown out of the community's love and passion for the weed culture. Launched around early 2025, $weedcoin, “Like Bitcoin but way higher,” emphasizes its alignment with cannabis culture and a laid-back vibe. Unlike other Weed communities, this project leans heavily into community engagement over technical utility, aiming to build a “stoner community” through social media presence and decentralized governance. We also aim to focus on onboarding web2 businesses and users onto web3 through the token.

Weedcoin

Weedcoin is trending as its community rallies around the upcoming 4/20 cultural event and its mission to champion global cannabis legalization, frequently proclaiming itself "like Bitcoin but way higher" as it builds a long-term "culture coin" on Solana.

Aster is a next-generation decentralized perpetual exchange that combines non-custodial trading with advanced features like hidden orders and multi-chain support. The platform emerged from the merger of Astherus and APX Finance in late 2024, with APX token holders able to migrate their holdings to ASTER.  Aster addresses the gap between centralized and decentralized exchanges by enabling traders to maintain full control of their assets while accessing deep liquidity and CEX-grade trading tools. The platform supports trading of both cryptocurrency perpetuals and U.S. stocks with up to 100x leverage, all settled on-chain in crypto without requiring traditional financial infrastructure.  The platform offers two distinct trading modes to accommodate different user needs. Simple Mode provides one-click, MEV-resistant trading with up to 1001x leverage for beginners, while Pro Mode delivers a full order book with advanced features like automated grid trading and hidden orders that remain invisible until execution.   Aster operates across BNB Chain, Ethereum, Solana, and Arbitrum without requiring bridging, with liquidity pooled across markets to support large trades with minimal slippage. A distinctive feature allows users to deposit yield-generating assets like asBNB or USDF as collateral, earning passive returns while trading, maximizing capital efficiency compared to platforms where collateral sits idle.  Aster received backing from YZi Labs (formerly Binance Labs), which holds a minority stake through a private fund managing over $10 billion on behalf of early Binance executives. Changpeng Zhao, founder of Binance, serves in an advisory role and has personally invested over $2.5 million worth of ASTER tokens.   The ASTER token serves multiple functions including governance rights, staking rewards through liquidity provision, and earning incentives through the platform's points program for traders and liquidity providers.

ASTERION

ASTER is intensely trending following reports of a personal endorsement and purchase by CZ, sparking widespread community debate about its potential to rival other perpetual decentralized exchanges like Hyperliquid, while bullish sentiment is also driven by recent listings and its significant token buyback program.

Bankr is an advanced AI agent focused on simplifying the process of buying and selling digital assets. Bankr was the first AI agent on Farcaster to help you quickly buy all your favorites coins directly in the social. BankrCoin is the official coin of the agent and was deployed by Bankr itself directly in the Farcaster social feed. Fees from swaps go to support BankrCoin. Bankr is available on Farcaster and will soon be launching a private terminal, token recs, and limit orders on Base.

BankrCoin

BNKR CRYPTO is trending due to its AI agent technology and deep integration within the Coinbase Base ecosystem, with recent exchange listings and the launch of the BankrWallet browser extension amplifying community excitement. Enthusiasts are actively buying dips, anticipating a significant price repricing and highlighting its consistent daily fee revenue, even as some question its volatility.

CRISPR Therapeutics AG is a gene editing company, which engages in the development of transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 platform. Its CRISPR/Cas9 platform is a gene editing technology that allows for precise, directed changes to genomic DNA. The firm offers a portfolio of therapeutic programs across a broad range of disease areas including hemoglobinopathies, oncology, regenerative medicine, and rare diseases. The company was founded by Rodger Novak, Emmanuelle Charpentier, Shaun Patrick Foy, Matthew Porteus, Daniel Anderson, Chad Cowan, and Craig Mellow on October 31, 2013 and is headquartered in Zug, Switzerland.

CRISPR Therapeutics AG

CRSP is generating significant discussion following a recent insider share sale by its CEO that has fueled negative sentiment and contributed to stock volatility, while the community actively weighs rumors of a potential buyout and anticipates key pipeline updates, including for its Casgevy gene therapy, ahead of upcoming healthcare conferences.

Pyth Network is a decentralised oracle network designed to provide real-time financial market data to decentralised applications (dApps) across multiple blockchains. It allows developer to secure smart contracts with reliable, low-latency market data from institutional sources, and build apps with high-fidelity oracle feeds designed for mission-critical systems.

Pyth Network

Pyth Network is gaining traction following the launch of its PYTH Reserve, which uses monthly network revenue for systematic token buybacks, and its expansion into institutional RWA price feeds. Community sentiment highlights Pyth's role as a leading oracle in the 'RWA next meta,' with many anticipating significant growth driven by its robust utility and revenue-based tokenomics.

CleanSpark, Inc. is a bitcoin mining technology company, which engages in the management of data centers. Its operations include College Park, Norcross, Washington, Sandersville, Dalton, and Massena. The company was founded by S. Matthew Schultz and Bryan Huber on October 15, 1987 and is headquartered in Henderson, NV.

Cleanspark Inc

A wider-than-expected loss and revenue miss has ignited polarized community discussion around CleanSpark's strategic pivot into AI/HPC data centers and energy infrastructure, with investors weighing the long-term vision against current Bitcoin market volatility and high short interest.

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Hims & Hers Health Inc - Ordinary Shares - Class A

Hims & Hers Health Inc

Hims & Hers Health is experiencing extreme volatility after rapidly halting its new compounded GLP-1 weight-loss pill following FDA enforcement signals and a Department of Justice referral. The community is fiercely debating whether this regulatory setback spells disaster for the company or merely removes an overhang, creating a buying opportunity for its broader telehealth business amidst intense competition from big pharma.

Omeros Corp. operates as a biopharmaceutical company. The firm engages in the discovery, development, and commercializing of both small-molecule and protein therapeutics for large market. It also offers orphan indications targeting inflammation, coagulopathies, and disorders of the central nervous system. The company was founded by Gregory A. Demopulos and Pamela Pierce Palmer on June 16, 1994 and is headquartered in Seattle, WA.

Omeros Corporation

Omeros Corp

Omeros is generating significant discussion after its FDA-approved, life-saving TA-TMA drug, YARTEMLEA, began commercial shipments, though many investors are frustrated by the stock's "irrational" valuation, which they largely attribute to market manipulation despite the strong revenue outlook and the company's major partnership with Novo Nordisk.

Intellia Therapeutics, Inc. is a clinical stage genome editing company, which engages in the development of curative therapeutics using the CRISPR/Cas9 system. Its CRISPR/Cas9 system transforms medicine by both producing therapeutics that permanently edit and/or correct disease-associated genes in the human body with a single treatment course, and creates engineered cells that can treat oncological and immunological diseases. The company was founded by Andrew May, Luciano Marraffini, Rodolphe Barrangou, Nessan Bermingham, Rachel Haurwitz, Erik Sontheimer, Jennifer Doudna, and Derrick Rossi in May 2014 and is headquartered in Cambridge, MA.

Intellia Therapeutics Inc

Intellia Therapeutics is trending as the FDA lifted the clinical hold on its MAGNITUDE-2 Phase 3 trial, boosting confidence in its gene-editing platform and sparking community discussions about a potential short squeeze. However, investors are also closely watching for updates on the remaining hold for its larger ATTR-CM trial.

Datadog, Inc. engages in the development of a monitoring and analytics platform for developers, information technology operations teams and business users. Its platform integrates and automates infrastructure monitoring, application performance monitoring and log management to provide real-time observability of its customers' entire technology stack. The company was founded by Olivier Pomel and Alexis Lê-Quôc on June 4, 2010 and is headquartered in New York, NY.

Datadog Inc - Ordinary Shares - Class A

Datadog Inc

Datadog is trending amid a wave of analyst upgrades emphasizing its robust growth and position as a key AI infrastructure beneficiary, even as the software sector faces broader concerns about competition and AI disruption. The community is actively discussing whether the recent pullback presents a compelling buying opportunity for this cloud observability leader.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

<ul class="summary-bullets"><li>CoreWeave joins the growing list of companies looking to capitalize on the Trump administration’s push for the use of AI by federal agencies.&nbsp;</li><li>The company said that the initiative was, in part, driven by the accelerating adoption of AI by federal agencies for training and inference.</li><li>CoreWeave added that it has already started investing in the teams, tools, and technologies that agencies require to meet these demands.</li></ul>CoreWeave (CRWV) announced on Tuesday that&nbsp;it is expanding its business into the U.S. federal market with ‘CoreWeave Federal’&nbsp;at Nvidia’s (NVDA) GTC CPU Technology Conference.The company said it plans to enter the federal market through a “deliberate approach” that adapts its industry-leading AI cloud platform to meet the U.S. government’s evolving cybersecurity standards and compliance requirements.&nbsp;<a href="http://stocktwits.com/symbol/CRWV">CRWV’s stock</a> gained 1.8% in afternoon trade, but retail sentiment on Stocktwits around the company remained in ‘bearish’ territory over the past day. The announcement comes as Core Scientific (CORZ) shareholders are being&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/van-eck-opposes-core-scientific-merger-with-core-weave-citing-ai-potential/cLG4mJxR3rO">urged</a> to vote against the company’s merger with CoreWeave, set for October 30.<h2 class="st-heading-2">CoreWeave’s Foray Into AI Government Contracts</h2>CoreWeave said its new product is going to focus on delivering secure, compliant, high-performance AI cloud&nbsp;servers to U.S. government agencies and their partners, such as the Defense Industrial Base. It added that this initiative was, in part, driven by the accelerating adoption of AI by federal agencies for training and inference.<blockquote>“America’s economic competitiveness and national security rely on the continued advancement of secure, high-performance AI infrastructure.”– Michael Intrator, Co-founder, Chairman, and Chief Executive Officer, CoreWeave</blockquote>The company stated that it has already started investing in the teams, tools, and technologies that agencies require to meet these demands, aligning its platform with FedRAMP and other authorizations.<h2 class="st-heading-2">Building On The U.S. Government’s Appetite For AI</h2>In July, the Trump administration released its ‘AI Action Plan’ as a follow-up to the President’s executive order in January to increase the use of AI across federal agencies. In addition to large companies like CoreWeave and Palantir capitalizing on the opportunity, smaller startups have also been roped into the push. The Department of Defense has awarded contracts worth up $200 million each to Anthropic, Google, OpenAI, and Elon Musk’s xAI.Read also:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/nokia-shares-surge-after-nvidia-announces-1-billion-investment-for-3-stake/cLGjZdER3vb">Nokia Shares Surge After Nvidia Announces $1 Billion Investment For Nearly 3% Stake</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, the logo of AI cloud-computing startup CoreWeave is displayed on a smartphone screen on May 16, 2025 in Suqian, Jiangsu Province of China. 

CoreWeave Targets Government Contracts With New AI Cloud Offering

The company said that the initiative was, in part, driven by the accelerating adoption of AI by federal agencies for training and inference.

Equity

Is American Century U.S. Quality Growth ETF (QGRO) a Strong ETF Right Now?

Fidelity Covington Trust - Fidelity Blue Chip Growth ETF

Up 5%

Down 5%

Markets are hovering near key levels, making the next 5% move especially important for sentiment. A breakout higher could reinforce the bull case, while a 5% drop may signal rising risk and tighter conditions. Which comes first?

Current Price	$53.63
Prev Close	$52.15
Open	$52.56
Dividend Yield	N/A
50-Day Moving Average	$54.78
Beta	N/A
Avg. Volume	662,066.30
PE Ratio	N/A

52-Week High	$56.50
52-Week Low	$33.57
Market Capitalization	N/A
EPS (Annual)	N/A
Price to Book	N/A
Revenue Per Employee	N/A
Enterprise Value/EBITDA	N/A

FBCG
Fidelity Blue Chip Growth ETF

Feed

News

Sentiment

Fundamentals

Info

Latest FBCG News

FBCGFidelity Blue Chip Growth ETF